Valuation: CellSource Co., Ltd.

Market Cap 6.23B 38.07M 33.44M 31.1M 28.53M 53.61M 3.67B 54.44M 369M 144M 1.8B 143M 140M P/E 2026 *
105x
P/E 2027 * 57.1x
Enterprise Value 6.23B 38.07M 33.44M 31.1M 28.53M 53.61M 3.67B 54.44M 369M 144M 1.8B 143M 140M EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.64x
Free-Float
45.73%
Yield 2026 *
-
Yield 2027 * -
1 day-3.09%
1 week-8.19%
Current month+0.64%
1 month+4.67%
3 months-14.67%
6 months-25.77%
Current year-21.30%
1 week 314
Extreme 314
342
1 month 299
Extreme 299
358
Current year 294
Extreme 294
442
1 year 294
Extreme 294
711
3 years 294
Extreme 294
2,600
5 years 294
Extreme 294
8,160
10 years 294
Extreme 294
8,160
Manager TitleAgeSince
Chief Executive Officer 62 2025-10-31
Director of Finance/CFO - 2025-12-31
Corporate Officer/Principal - 2023-12-31
Director TitleAgeSince
Director/Board Member 64 2017-05-31
Director/Board Member 58 2025-12-31
Chairman 62 2024-01-24
Change 5-day change 1-year change 3-year change Capi.($)
-3.09%-8.19%-55.96%-86.53% 39.24M
+0.63%-3.06%+16.18%-9.78% 66.32B
+1.23%+2.80%+37.51%+202.14% 52.6B
+10.08%+51.80%+51.80%+51.80% 43.27B
-1.32%-7.38%-57.63%-57.10% 38.64B
+0.78%-1.84%+52.49%-27.01% 29.62B
+0.84%+0.36%+66.93%+85.42% 23.31B
-5.17%-12.54%+58.98%-56.04% 22.62B
-1.21%+1.12%+1.98%+170.93% 20.22B
-0.22%-0.95%+61.97%+123.78% 16.29B
Average +0.85%-1.73%+23.43%+39.76% 31.29B
Weighted average by Cap. +1.67%-0.40%+27.35%+49.24%

Financials

2026 *2027 *
Net sales 3.6B 21.99M 19.32M 17.96M 16.48M 30.97M 2.12B 31.45M 213M 83.34M 1.04B 82.56M 80.78M 3.8B 23.21M 20.39M 18.96M 17.4M 32.69M 2.24B 33.2M 225M 87.97M 1.1B 87.14M 85.27M
Net income 60M 367K 322K 299K 275K 516K 35.3M 524K 3.56M 1.39M 17.35M 1.38M 1.35M 110M 672K 590K 549K 504K 946K 64.71M 961K 6.52M 2.55M 31.81M 2.52M 2.47M
Net Debt - -
Logo CellSource Co., Ltd.
CellSource Co., Ltd. is a Japan-based company engaged in regenerative medicine related business and consumer business. The Company operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.
Employees
148
Date Price Change Volume
26-07-24 JP¥314.00 -3.09% 44,700
26-07-23 JP¥324.00 -1.52% 21,600
26-07-22 JP¥329.00 -1.20% 25,400
26-07-21 JP¥333.00 -2.63% 25,900
26-07-17 JP¥342.00 -0.29% 42,200
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4880 Stock